INTRODUCTION
Haemophilus influenzae is a human-adapted organism existing as a common commensal of the upper respiratory mucosa, and as a pathogen causing otitis media, sinusitis, bronchitis and community-acquired pneumonia. Chronic infection with H. influenzae can occur in patients with a lower airway disease, such as chronic obstructive pulmonary disease (COPD), bronchiechtasis and cystic fibrosis (CF) (Tang et al., 2001) . H. influenzae persists within the human respiratory tract by generating diversity through mutational mechanisms that produce antigenic and phase variation. The resulting phenotypic changes facilitate escape from immune detection and permit adaptation to a changing environment (Foxwell et al., 1998; Moxon et al., 1994) . An unresolved issue is the prevalence and the contribution to pathogenesis of so-called mutator, or hypermutable, strains of H. influenzae.
Hypermutable isolates of bacterial pathogens have been described among natural populations of Escherichia coli, Salmonella enterica, Pseudomonas aeruginosa, Neisseria meningitidis and Staphylococcus aureus (Bucci et al., 1999; Denamur et al., 2002; LeClerc et al., 1996; Matic et al., 1997; Oliver et al., 2000 Oliver et al., , 2002 Prunier et al., 2003; Richardson et al., 2002) . The majority of mutators among natural bacterial populations have been found to have defects in one or more components of the methyl-directed mismatch repair (MMR) system, particularly mutS (LeClerc et al., 1996; Li et al., 2003; Matic et al., 1997; Oliver et al., 2002) . The MMR system is responsible for correcting errors in newly replicated DNA and prevents recombination between homologous DNA sequences (Matic et al., 1995; Modrich & Lahue, 1996; Rayssiguier et al., 1989) . Mutants in MMR genes produce a global mutator phenotype with up to 1000-fold increased mutation rates, increased recombination between non-identical DNA sequences and increased rates of frameshift mutations, particularly in microsatellite regions with runs of repetitive sequences (Cox, 1976; Glickman & Radman, 1980; Matic et al., 1995; Schaaper & Dunn, 1987; Strauss, 1999) .
The prevalence of global mutators within some populations was estimated to be about 1 % of natural pathogenic and commensal isolates of E. coli and Sal. enterica, and considerably higher within specific conditions (i.e. up to 20 % of P. aeruginosa isolated from the sputum of patients with CF) (LeClerc et al., 1996; Matic et al., 1997; Oliver et al., 2000) . It is thought that the reason mutators are not more prevalent is due to the decreased fitness of excess deleterious mutations associated with higher mutation frequencies (Dawson, 1999) . However, when a favourable mutation, such as antibiotic resistance, is acquired and selected for, the hypermutable phenotype can stabilize and be propagated by association with the selective mutation (hitchhiking) (Chao & Cox, 1983; Giraud et al., 2002; Taddei et al., 1997a) . This has been demonstrated in a gnotobiotic mouse model in which antibiotic treatments not only selected for antibiotic-resistant bacteria, but also for MMR-defective mutators . Bacteria with high mutation frequencies are predicted to have a higher probability of survival in changing and unpredictable environments and have greater ability to adapt to new conditions, including antibiotic pressure Ishii et al., 1989; LeClerc et al., 1996; Leigh, 1970; Sniegowski et al., 1997; Taddei et al., 1997b) . Therefore, mutator bacteria are clinically important as they can promote the emergence of strains resistant to one or more antibiotics which increases hospitalization costs as well as patient morbidity and mortality (Carmeli et al., 1999) . A positive correlation has been found between high mutation frequencies and antibiotic resistance in P. aeruginosa isolates from CF patients receiving long-term antibiotic therapy (Oliver et al., 2000) .
The present study defines the prevalence of global hypermutators within a panel of H. influenzae isolated from a variety of patients, and commensal isolates. We identified several hypermutable strains, with the majority of those being isolated from CF sputum. The hypermutable phenotype of these isolates was associated with polymorphisms in conserved regions of mutS. In addition, six hypermutable isolates were discovered to be clonal, originating from the same CF patient collected over a period of about 11 months. These clonal isolates were further characterized to examine the effect of the hypermutable phenotype on antibiotic resistance over time.
METHODS
Bacterial strains and growth conditions. H. influenzae were grown on chocolate agar [per litre: 36 g Difco GC medium with agar (Becton Dickinson), 10 g haemoglobin, 10 ml isovitalex and 5 units bacitracin ml 21 ] or supplemented brain heart infusion (sBHI) broth or agar [per litre: 37 g BHI media±15 g Bacto agar (Remel) supplemented with 10 mg b-NAD ml 21 , 10 mg haem ml 21 , 10 mg histidine ml 21 and 5 units bacitracin ml 21 ]. Strains were incubated at 37 uC in room air. Antibiotic concentrations used for H. influenzae were (ml
21
) 25 mg rifampicin, 14 mg nalidixic acid, 20 mg spectinomycin, 2 mg chloramphenicol and 30 mg ribostamycin. Chemicals were purchased from Sigma unless otherwise specified. In some experiments bacteria were washed and resuspended in phosphate-buffered saline (pH 7?0) with 0?1 % gelatin (PBSg).
Five hundred H. influenzae isolates, both commensal and from a variety of diseases (Table 1) were screened for the hypermutable phenotype as described below. Isolates were obtained from 450 different patients, mostly from the area of Seattle, WA, USA, with 25 patients contributing two or more isolates over time. All isolates with the hypermutable phenotype on screening were confirmed as H. influenzae by Gram staining, oxidase testing and the requirement for X (haemin) and V (b-NAD + ) factors for aerobic growth. b-Lactamase production was detected with the nitrocefin dry slide test (Becton Dickinson). Encapsulation of strains was assessed by PCR for the presence of the capsule export locus (bexA) and, if present, PCR for the capsular gene cluster using primers specific for capsular types a-f (Falla et al., 1994) . Strains Rd KW20 (R652) (Wilcox & Smith, 1975) and Rd KW20 mutS : : TSTE (R3544) (Watson et al., 2004) were used as negative and positive controls, respectively, for determination of mutation frequency.
DNA manipulations, PCR and sequencing. Bacterial genomic DNA was prepared using the DNeasy Tissue kit from Qiagen. All PCR amplicons were partially purified using the Qiaprep PCR (Meats et al., 2003) .
Determination of mutation frequency. All 500 isolates were initially screened by assessment of the mutation frequency to rifampicin resistance and were considered potential hypermutators if they yielded ¢10 rifampicin-resistant c.f.u. per 10 9 viable cells. This value was chosen as it is approximately 10 times the mutation frequency of strain Rd KW20 and is similar to the mutation frequency of a constructed mutS : : TSTE mutant of Rd KW20 (R3544) (Watson et al., 2004) . Potential mutators were confirmed with additional measurement of mutation frequency to rifampicin, nalidixic acid and spectinomycin resistance assessed on sBHI agar plates. Fluctuation assays (Luria & Delbruck, 1943) were performed by inoculating 10 ml sBHI broth in a 125 ml flask to achieve an initial density of 10 7 c.f.u. ml 21 of H. influenzae and growing for 8-10 h shaking at 200 r.p.m. in 37 uC in room air. For unclear reasons, H. influenzae requires a relatively high inoculum density to achieve growth in sBHI liquid medium. The culture density after growth was approximately 10 10 c.f.u. ml
. Cultures were pelleted and resuspended in 500 ml PBSg. From these concentrated cultures 100 ml was spread in duplicate onto sBHI plates containing rifampicin, nalidixic acid or spectinomycin to determine the number of drug-resistant mutants per ml of culture. Another 100 ml of the same culture was serially diluted in PBSg and plated in duplicate on sBHI plates without antibiotics to determine the viable cell count per ml of concentrated culture. Growth was allowed for 48 h at 37 uC in room air prior to quantification. Mutation frequency was calculated as the number of drug-resistant cells per ml of culture divided by the total number of viable cells per ml of culture. Because the mutation frequency fluctuates between individual cultures, at least four independent measurements were sampled in duplicate for each strain with the median mutation frequency reported. Using the median frequency method of Drake (1991) an estimate was made of the mutation rate, defined as antibioticresistant bacteria produced per cell per division. It should be noted that due to the relatively high inoculum density required to achieve growth in broth media, some experiments could possibly have contained pre-existing mutants in strains with the highest mutation rate which would tend to lead to an overestimation of the mutation frequency. The combined effect of multiple replicates and reporting the median mutation frequency rather than the mean was used to minimize the effect of these artificial 'jackpots'.
Enterobacterial repetitive intergenic consensus (ERIC)-PCR
fingerprinting. Random amplification PCR analysis was performed using primers ERIC 1 or ERIC 2. Primer sequences and reaction conditions were as described by Gomez-De-Leon et al. (2000) . A negative control containing all reaction ingredients except for template DNA was run in parallel to each experiment and results were analysed only if the negative control failed to yield amplified DNA. The amplification products (8?5 ml) were separated by 2?0 % agarose gel electrophoresis at 5 V cm 21 for 5-7 h with subsequent staining by ethidium bromide. Amplification reactions were repeated a minimum of three times to verify the reproducibility of the ERIC-PCR banding profiles.
Ribotyping of bacterial isolates. Genomic DNA was prepared for each isolate and 10 mg DNA was digested with 10 units EcoRI. Digested DNA was separated by 0?8 % agarose gel electrophoresis and subsequently transferred to nylon membranes. Membranes were blotted with a DIG-labelled probe for H. influenzae 16S rRNA genes (rrnABCDEF) generated from the 740 bp PCR product of primers rrnB F and rrnB R. Hybridization was detected by chemiluminescence using an alkaline phosphatase antibody against digoxigenin.
MLST. MLST was performed for H. influenzae as described by Meats et al. (2003) . The sequences were aligned and allele assignments were produced at the MLST website (www.mlst.net). Novel allele sequences identified in this work were submitted to the H. influenzae MLST database and assigned numbers by the database curator, Emma Meats.
Antibiotic susceptibility testing. The close-interval MIC was determined using agar dilution and a Steer's replicator (Steers et al., 1959) . Plates of sBHI with antibiotic concentrations of 0, 0?125, 0?25, 0?5, 1, 2, 4, 8, 16, 32 and 64 mg amoxycillin, ampicillin, cefaclor, ceftriaxone, cephalexin, chloramphenicol, ciprofloxacin, tetracycline, ticarcillin and tobramycin ml 21 were prepared. Bacteria were harvested from fresh overnight growth at 37 uC in room air on chocolate agar and resuspended in PBSg to an OD 600 of 0?2, which corresponds to approximately 1610 8 c.f.u. ml
21
. This suspension was diluted 1 : 10 in PBSg and 150 ml was loaded into the wells of the multi-pin Steer's replicator; the multi-pin head was dipped into the wells and then gently applied to the surface of the agar plates. The pins deposit a volume of approximately 10 ml to the plate surface from each well which results in 10 5 c.f.u. delivered per spot. After drying for 30 min, the plates were incubated at 37 uC for 36 h in room air before reading. Inocula with less than 10 % growth relative to the antibiotic-free plate were considered negative for growth at that antibiotic concentration (Syriopoulou et al., 1979) . H. influenzae strain ATCC 49766 was used as a control for ampicillin susceptibility testing with MICs interpreted using the recommendations in NCCLS standard M100-S11 (NCCLS, 2001) . Antibiotic susceptibility tests were repeated three times and the mean MIC value reported.
Sequencing of mutS alleles from hypermutable isolates.
Genomic DNA from each strain was prepared to sequence mutS using overlapping primer sets listed in Table 2 . Each primer set yields a product of about 500-1000 bp and the products were sequenced in both forward and reverse directions with the same primers used for amplification. PCR products were amplified using the Expand High Fidelity Polymerase (Roche) for maximal accuracy and were subsequently visualized by 0?8 % agarose gel electrophoresis, purified and sequenced at the SBRI DNA core facility. Sequences were aligned with the Bioedit Sequence Alignment Editor for Windows which is available online as freeware at www.mbio. ncsu.edu/BioEdit/bioedit.html. The mutS sequences from H. influenzae strains Rd KW20 (Fleischmann et al., 1995) , Strain-12 (R2846; unpublished data), INT-1 (R2866; unpublished data) and E. coli strain K-12 (Blattner et al., 1997) were used as a template for general alignment of mutS sequences. Multisequence alignments were also performed using CLUSTAL W available at http://clustalw.genome. ad.jp/ (Thompson et al., 1994) .
Cloning of mutS alleles for complementation analysis. The mutS genes were cloned for complementation analysis. To clone mutS, primers XbaI MutS F and XbaI MutS R were used to amplify mutS from genomic DNA of H. influenzae strains without tnaCAB upstream of mutS, and primers MutS Front F and XbaI MutS R were used for strains with tnaCAB. These primer sets produce 3 kb amplicons with XbaI sites at both the 59 and 39 ends, and these sites were used to ligate the XbaI-digested mutS sequences into XbaIdigested pSU2718, an E. coli to H. influenzae shuttle vector Downloaded from www.microbiologyresearch.org by IP: 54.70.40.11
On: Sat, 09 Mar 2019 22:21:37 (Martinez et al., 1988) . Following transformation and confirmation of cloning in E. coli DH5a, plasmids were purified and resuspended in Nanopure water for electroporation into H. influenzae strain R3544 (Rd KW20 mutS : : TSTE) with selection on chocolate agar plates supplemented with 2 mg chloramphenicol ml 21 . Electroporation of plasmids into H. influenzae was performed as described by Mitchell et al. (1991) . Strain R3544 transformed with plasmids encoding various mutS alleles was tested for complementation of the mutator phenotype by measuring mutation frequency to rifampicin resistance (25 mg ml 21 ) on sBHI plates as described above. 
RESULTS

Screening and detection of hypermutable H. influenzae isolates
Five hundred isolates from the collection of one of the authors (A. L. S.) were selected to obtain a panel from diverse patient sources (Table 1 ). The majority of the isolates were previously identified by the clinical microbiology service as non-typable; 42 isolates from blood or CSF were previously determined to be type b. The commensal isolates were isolated during screening of children at well-child physician visits to define the prevalence of antibiotic resistance. Using a single measurement of spontaneous mutation frequency to rifampicin resistance as an indicator, 27 of 500 isolates (5?4 %) were initially scored as possible hypermutators and were further tested by additional fluctuation tests to rifampicin, nalidixic acid and spectinomycin resistance. Fourteen of the 500 isolates (2?8 %) were confirmed as having a hypermutable phenotype and results of mutation frequency testing are shown in Table 3 . The mutation rates to rifampicin and nalidixic acid resistance of strain Rd KW20 mutS : : TSTE (R3544) are about eightfold greater than the mutation frequency of the parent strain Rd KW20 (R652) due to insertional inactivation of the MMR protein mutS (Watson et al., 2004) . These mutation rates are comparable to previously reported mutation rates to rifampicin and nalidixic acid resistance for strains Rd KW20 and Rd KW20 DmutS (Bayliss et al., 2002 (Bayliss et al., , 2004 . The mutation rates of the natural hypermutable isolates were variable and ranged from about 5-to 380-fold greater than Rd KW20 (R652). These mutation frequency values are consistent with a previous report describing H. influenzae mutation frequencies to rifampicin resistance ranging from 10 29 to 10 26 (Mendelman et al., 1982) . Some isolates produced higher mutation frequencies to one antibiotic compared to the others. Two isolates, C2394 and R465, were hypermutable to rifampicin and nalidixic acid resistance, but had a much lower frequency of spontaneous mutation to spectinomycin resistance. Thirteen of the 14 (92?9 %) hypermutable isolates were non-typable, defined as lacking the capsule export locus bexA by PCR. One isolate of the 14 (7?1 %), C2202, contained bexA, and further testing using PCR primers specific for capsular serotypes a-f (Falla et al., 1994) identified it as a type b encapsulated strain. Twelve of the 14 (85?7 %) hypermutable isolates were CF sputum isolates, which was 8?3 % of the total 145 CF sputum isolates tested. One mutator was an invasive blood isolate (C2202) and one was a conjunctivitis isolate (C2475). Pettigrew et al., 2002; van Belkum et al., 1994) . We found PCR using only one primer per reaction provided more distinctive and reproducible amplification profiles. Fig. 1 shows ERIC-PCR fingerprints for the 14 hypermutable isolates. Using the ERIC-1 primer, eight distinct PCR banding profiles were produced with amplicon sizes ranging from 300 to 1800 bp. Six isolates (C2408, C2561, C2562, C2687, C2692 and C2696) produced identical amplicon patterns. Two other isolates (C2621 and C2677) had identical patterns distinct from all other strains. PCR amplification with the ERIC-2 primer produced different amplicon patterns, but still differentiated the 14 isolates into eight distinct profiles with the same isolates showing identical banding profiles as seen with the ERIC-1 primer. In addition, ribotyping of EcoRI restricted genomic DNA was performed for the hypermutable isolates using a DIGlabelled probe for H. influenzae 16S rRNA (rrnABCDEF).
Restriction with EcoRI produced only three distinct ribotypes with fragment sizes ranging from 300 to 6000 bp (data not shown); ribotyping with EcoRI is known to be limited in its discriminatory ability among non-typable isolates (Sharma et al., 2002) . Six isolates (C2408, C2561, C2562, C2687, C2692 and C2696) produced an identical ribotype pattern, distinct from all other strains. Strain R465 produced a unique ribotype, and the ribotypes of the remaining strains were indistinguishable. A review of medical records, with approval of the Children's Hospital and Regional Medical Center Institutional Review Board, revealed that these six isolates with identical ERIC-PCR and ribotype patterns were all isolated over a period of about 11 months from the same patient; a male child with CF. MLST (Maiden et al., 1998; Meats et al., 2003) of adk, atpG, frdB, fucK, mdh, pgi and recA, confirmed these six strains were clonal, providing strong evidence that hypermutable strains C2408, C2561, C2562, C2687, C2692 and C2696 evolved from a common ancestor (allele designations of strain C2696 were archived in the H. influenzae MLST database). From these results it was concluded that eight genetically distinct hypermutable strains were isolated.
Sequencing of mutS in hypermutable isolates
The majority of natural hypermutable isolates described in other bacterial pathogens have been found to have point No DNA  R465  C2696  C2692  C2687  C2677  C2621  C2562  C2561  C2475  C2408  C2394  C2382  C2372  C2202  100 bp  No DNA  R465  C2696  C2692  C2687  C2677  C2621  C2562  C2561  C2475  C2408  C2394  C2382  C2372  C2202  100 bp ERIC-1 primer ERIC-2 primer mutations or deletions in all or part of the mutS gene which inactivates the MMR system (LeClerc et al., 1996; Li et al., 2003; Matic et al., 1997; Oliver et al., 2000) . The mutS alleles from each of the eight distinct members of the hypermutable panel were sequenced in an attempt to identify mutations in regions previously shown to be essential for mutS function in other organisms. Strain C2696 was sequenced as a representative of the clonal CF mutator strains determined by MLST. Strain C2677 was sequenced as a representative of C2677 and C2621; these strains were found to be identical by ERIC-PCR and ribotyping, and were both isolated from a separate child with CF. For comparison to alleles of mutS from non-hypermutable strains, the mutS sequences of H. influenzae Rd KW20 (Fleischmann et al., 1995) , Strain 12 (R2846; unpublished data) and INT-1 (R2866; unpublished data), were included as well as mutS from E. coli K-12 (Blattner et al., 1997) . The online version of this paper (at http://mic.sgmjournals.org) contains a supplementary figure showing the alignment of the mutS sequences described here. DNA sequences of the mutS ORF from most strains were 2586 bp in length, with the exceptions of strain C2696, which was 2583 bp in length, and C2372, which was 2585 bp in length. DNA sequences of H. influenzae mutS shared a minimum identity of 94 % with each other, but were considerably polymorphic with a great number of both synonymous and non-synonymous nucleotide substitutions. In general, the predicted amino acid sequences of H. influenzae MutS proteins were about 99 % similar to each other, indicating the majority of polymorphisms in the DNA sequences were conservative mutations. No single mutation was identified in the predicted MutS sequence that was capable of distinguishing high-level mutators from moderate-level mutators. The predicted MutS protein of strain C2372 is only about 78 % similar to the other strains. Examination of the DNA sequence of this strain identified a deletion of thymine 1911 which results in a frameshift mutation and a premature TAA stop codon being introduced after amino acid position 636. This truncates the MutS protein and removes 225 aa from the C-terminus, a region previously shown in E. coli MutS to be necessary for homodimerization and interaction with MutL (Wu & Marinus, 1999) . The predicted MutS protein sequence of strain C2696 lacks a conserved histidine residue at position 74. Examination of the DNA sequence of this strain identified a deletion of three nucleotides after nucleotide 219, which removes the codon for histidine, but keeps the remainder of the codons in the proper reading frame. Deletion of the N-terminal 300 aa in E. coli MutS eliminates DNA binding but preserves interaction with downstream proteins (Wu & Marinus, 1999) . Histidine 74 is within the DNA binding region and may be required for DNA binding activity. The predicted MutS protein sequence of strain C2394 has two mutations in conserved amino acid positions: R198G and Q628P. Arginine 198 is located in the region required for DNA binding in E. coli MutS, and glutamine 628 is located near the P-loop motif required for nucleoside triphosphate binding and ATPase activity (Wu & Marinus, 1999) . Mutations in the E. coli P-loop region are associated with a dominant negative mutator phenotype, presumably because mismatches are bound by defective MutS in an irreversible manner preventing further repair (Wu & Marinus, 1994) . The predicted MutS protein sequence of strain C2475 has a mutation in a conserved residue: R563C. Deletion of this region has been shown to eliminate homodimerization in E. coli MutS and to eliminate DNA binding in MutS of Thermus thermophilus (Tachiki et al., 1998) . The predicted MutS protein sequence of strain C2382 has a mutation, T615P, in the conserved P-loop motif region required for ATPase activity. The predicted MutS protein sequence of strain R465 has two mutations in conserved amino acid positions: S670L and G743S. Both of these mutations occur in regions previously shown to be necessary in E. coli for homodimerization and interaction with MutL (Wu & Marinus, 1999) . The predicted MutS protein sequence of strain C2677 also has a mutation in the conserved residue G743S.
The region upstream of mutS was PCR-amplified using the MutS promoter F-R primer pair or the MutS Front F and the MutS promoter R primer pair. The PCR products of strains C2677 and C2382 were of equal size (about 530 bp) to the Rd KW20 PCR product. The PCR products of strains C2696, C2372, C2394, C2202, C2475 and R465, were each about 3?7 kb. Partial sequencing of these large amplicons identified the presence of the tryptophanase operon (tnaCAB); these strains were all indole-positive (data not shown). This operon has been previously shown to be widespread (70-75 %) among commensal respiratory isolates but more prevalent (94-100 %) in disease isolates (Martin et al., 1998) . All strains examined were nearly identical in their DNA sequence in the first 70 bp upstream of mutS. Further upstream sequences shared much less identity due to the presence of the tnaCAB operon in six of the strains. The hypermutable strain C2382 has a deletion of five conserved nucleotides about 30 bp upstream of the mutS ATG codon within the putative promoter region.
mutS alleles are defective in trans
To determine if mutS alleles sequenced in this study were defective, complementation analysis was used: we cloned mutS alleles into the plasmid pSU2718 and then tested the ability of these plasmids to suppress the mutator phenotype of Rd KW20 mutS : : TSTE (R3544). Table 4 lists the mutation frequency to rifampicin resistance for the Rd KW20 mutS : : TSTE (R3544) mutator strain transformed with various plasmid constructs. Strain R3544 has a mutation rate about eightfold greater than the parental strain R652; the addition of the pSU2718 vector by itself did not significantly alter the R3544 mutation frequency (two-tailed Mann-Whitney test, P=0?144). Strain R3544 carrying the pMW058 plasmid with the R652 wild-type mutS allele had a significantly reduced mutation frequency (P<0?0005). Strain R3544 with either pMW059, pMW060 or pMW064 did not have a significantly reduced mutation frequency compared to R3544 alone (P=0?168 for each). Strain R3544 with the pMW065 plasmid had an intermediate mutation frequency that was significantly reduced from the R3544 parent strain (P<0?001), but remained significantly greater than R3544 with plasmid pMW058 (P<0?01).
Detection of b-lactamase-negative ampicillinresistant (BLNAR) hypermutable isolates
Bacterial strains with elevated mutation rates have an increased frequency of antibiotic resistance due to mutations in the target for the antibiotic or modifications in antibiotic permeability. In H. influenzae, resistance to blactam antibiotics, such as ampicillin, occurs commonly through production of plasmid-mediated TEM-1 (Vega et al., 1976) or ROB-1 (Medeiros et al., 1986) b-lactamases and less commonly by mutations in penicillin-binding proteins (PBPs) resulting in a lower affinity for b-lactams or a reduction in the drug permeability (Mendelman et al., 1990a (Mendelman et al., , 1984 . BLNAR isolates are often resistant to firstand second-generation cephalosporins (Mendelman et al., 1990b; Powell & Williams, 1988) . The hypermutable panel was tested for the presence of BLNAR isolates. All of the hypermutable isolates were screened for b-lactamase production using the nitrocefin dry slide test: two isolates, C2475 and C2382, produced the enzyme, while in the remaining 12 it was not detectable. All isolates were tested by the agar dilution method for antibiotic susceptibility to ampicillin, amoxycillin, cefaclor and ceftriaxone (Table 5 ). The two isolates producing b-lactamase exhibited high-level resistance (MIC>64 mg ml
21
) to ampicillin and amoxycillin, and both were resistant to cefaclor (MIC¢32 mg ml
). All isolates were susceptible to ceftriaxone, (MIC=0?125 mg ml 21 ). One isolate, R465, lacked detectable b-lactamase activity and was found by agar dilution to be resistant to ampicillin and amoxycillin (MIC=16 mg ml 21 ), and had high-level resistance to cefaclor (MIC>64 mg ml 21 ); this isolate was considered to be BLNAR. It was found to have non-conservative point mutations in PBP3, conferring resistance to several b-lactam antibiotics (Valentine and Smith, unpublished data). Several isolates were resistant to cefaclor (MIC¢32) but susceptible to ampicillin or amoxycillin (MIC¡1).
Evolution of antibiotic resistance in a clonal hypermutable strain
Six hypermutable isolates of clonal origin were isolated over about 11 months from the same child with CF (C2408, C2561, C2562, C2687, C2692 and C2696). A review of medical records indicated that this patient received ticarcillin/ clavulinic acid, tobramycin and cephalexin throughout the 11 month period that these isolates were collected. We hypothesized that the persistent hypermutable H. influenzae strain isolated from this patient was selected for and maintained over time by constant antibiotic pressure. The antibiotic susceptibilities of these clonal hypermutable isolates were examined to a panel of additional antibiotics (Table 6 ). No differences in antibiotic susceptibilities were found for cephalexin (all resistant), ciprofloxacin (all susceptible) and tetracycline (all susceptible). The MIC doubled for chloramphenicol from 0?5 to 1?0 mg ml 21 for the three isolates C2687, C2692 and C2696. The MIC for ticarcillin quadrupled from 1?0 mg ml 21 for C2408, to 4?0 mg ml 21 for C2687, C2692 and C2696. Tobramycin resistance increased from an MIC of 4?0 mg ml 21 for the first isolate C2408, then increased to 64 mg ml 21 for C2561, then decreased to 32?0 mg ml 21 for C2562 and stabilized at 16?0 mg ml 21 for the remaining isolates C2687, C2692 and C2696. In addition, the antibiotic susceptibilities for ampicillin, amoxycillin and cefaclor also doubled for the three isolates C2687, C2692 and C2696 (Table 5) . Although these changes in susceptibility are modest, the close-interval MIC testing demonstrates how a natural hypermutable strain may evolve antibiotic resistance over time. DMutation rates were estimated using the median frequency method of Drake (1991) . dThe -fold increase in mutation rate is relative to strain R652.
DISCUSSION
Hypermutability among natural isolates of bacterial pathogens has received increasing attention relatively recently; it seems an emerging theme is that many, if not all, bacterial species studied in detail will be found to have a relatively high proportion with increased mutation frequencies. We have found hypermutable isolates within a diverse panel of H. influenzae. Of 500 isolates tested, 14 (2?8 %) were hypermutable and subsequent genetic analysis identified eight unique hypermutable strains, with six of the eight (75?0 %) unique mutators being CF sputum isolates. These percentages are comparable to the original description (LeClerc et al., 1996) of hypermutable E. coli and Sal. enterica at frequencies of greater than 1 % in natural populations and reflects the increase in hypermutable isolates recoverable from specific disease conditions. Sputum from CF patients has previously yielded a high percentage of hypermutable isolates of P. aeruginosa and Sta. aureus (Matic et al., 1997; Oliver et al., 2000; Prunier et al., 2003) . The high frequency of mutators in CF sputum found in our study and by others suggests that the hypermutable phenotype is advantageous in the CF lung environment, where repeated exposure to antibiotic therapy may select for and maintain strains with defects in DNA repair. Our screen may have missed a small number of additional hypermutable isolates due to poor growth of some H. influenzae clinical isolates under laboratory conditions. In addition, the clonality of the sample population as a whole was largely unknown, and as a result our percentage of hypermutable isolates in this population is an estimate and may actually be greater.
Hypermutable bacteria commonly have defects in genes *C2561 and C2562 were isolated on the same day by differences in colony colour. DAntibiotics that were administered to the patient during treatment for CF pulmonary infection. involved with DNA proofreading, such as mutS of the MMR system (LeClerc et al., 1996; Li et al., 2003; Oliver et al., 2002) . As a result of lesions that inactivate the MMR system, the global mutation rate increases (up to 1000-fold greater in E. coli) and the barrier to genetic recombination between divergent DNA sequences is lowered (Matic et al., 1995; Rayssiguier et al., 1989) . Mutants of mutS are more abundant than isolates with mutations in other MMR genes in natural populations of E. coli (LeClerc et al., 1996; Matic et al., 1997) . In contrast, in the laboratory environment mutants of other E. coli MMR genes, including mutL, are readily isolated, suggesting certain mutations may be counterselected against in nature due to deleterious effects that are not compensated by advantageous randomly generated mutations (Denamur et al., 2000) . We have found several mutations in mutS alleles from our hypermutator panel that were in regions associated with defective MutS activity in E. coli. Four of these mutS alleles were cloned and these failed to completely complement the mutator phenotype of strain Rd KW20 mutS : : TSTE (R3544), suggesting that these mutS alleles are defective and are likely to be responsible for a mutator phenotype. The mutS allele of strain C2394 in plasmid pMW065 partially complemented the R3544 mutator phenotype (Table 4) . C2394 is a moderate-level mutator with at least two mutations at conserved positions, and even though its MutS is defective, it still seems to retain some functions capable of partial complementation. In H. influenzae, mutants of mutS may be particularly common as mutS is an isolated ORF; in contrast, mutL and mutH are located within operons with several other genes involved in DNA metabolism, protein synthesis and cell envelope functions, and therefore only mutations which do not produce polar effects are more likely to be selected, potentially limiting the frequency of mutL and mutH mutations in nature. A similar explanation has been previously offered to account for the overrepresentation of natural E. coli mutS 2 mutators compared to mutL 2 mutators, with mutL in E. coli being part of an operon subject to polar mutations (Denamur et al., 2000) . In addition, in H. influenzae point mutations inactivating MMR activity may be preferred over gene deletions as the remaining DNA sequence following a point mutation may facilitate genetic recombination at a later time to reacquire a functional mutS allele from the environment by lateral transfer. However, it should be noted that no evidence exists to suggest deletions inhibit lateral transfer. The mutS region of E. coli is highly polymorphic and phylogenetic analysis between mutS alleles and their respective genomes suggests that mutS may have been transferred by horizontal exchange multiple times throughout E. coli populations to rescue defective mutS alleles (Brown et al., 2001) . The mutS sequences among our isolates were polymorphic and further comparison of these sequences to other housekeeping genes is required to determine if a similar mechanism is likely to occur in H. influenzae.
Antibiotic resistance has been previously correlated with the presence of the mutator phenotype in P. aeruginosa and Sta. aureus isolates from CF patients receiving long-term antibiotic therapy (Oliver et al., 2000; Prunier et al., 2003) . Among our panel of mutators we found one BLNAR CF sputum isolate (R465) out of 12 (8?3 %) non-b-lactamase-producing mutators, and seven of 12 (58?3 %) non-b-lactamase-producing mutator isolates were resistant to the second-generation cephalosporin cefaclor (MIC¢32 mg ml 21 ). H. influenzae BLNAR isolates are relatively rare in the United States with estimates ranging from <0?1 to 2?5 % of all isolates investigated (Doern et al., 1997) . The higher prevalence of hypermutable H. influenzae in patients receiving long-term antibiotic therapy, as in CF, may select and increase the frequency of BLNAR isolates recovered from those populations.
We have been able to identify six hypermutable CF sputum isolates from the same patient over a period of about 11 months that were determined by three independent genetic methods to have at least originated from the same ancestral strain, providing us with the ability to track the effects of the hypermutable phenotype on patterns of antibiotic resistance. Examination of antibiotic susceptibilities for these isolates with close-interval MIC testing showed increases in resistance for multiple antibiotics for some strains, mostly to the antibiotics the patient received as treatment for chronic respiratory infection. The significance of the MIC for tobramycin being unstable in these isolates is unknown, but may indicate that although these isolates are clonal in origin they may not be direct descendants of each other. These isolates may have originated from the same hypermutable ancestral strain and then underwent parallel evolution in different microenvironments of the CF lung. Parallel evolution of serial E. coli isolates with different antibiotic susceptibilities has been described (Low et al., 2001) . We believe these increases in resistance demonstrate the ability of a persistent hypermutable strain to evolve antimicrobial resistance over time and illustrate the difficulty of eradicating pathogens in diseases such as CF where small variations in antibiotic accessibility may create a microenvironment where resistant bacterial strains will emerge (Pennington, 1981) .
In summary, hypermutable clinical isolates of H. influenzae with mutations in mutS exist at relatively high frequencies, particularly in certain environments such as CF sputum. These isolates are capable of causing persistent infections and are likely to be selected for and maintained within natural populations by the benefits associated with an increased mutation frequency and a relaxed barrier to genetic recombination, producing isolates with new traits including antibiotic resistance.
